You see, I also have lines, and I don't think your level qualifies as an entry point. Would love to hear your thesis, please?
magnum375
⋅
@Barkworth, the support at 0.5 is a very strong support and I look into the financial of the company and they look strong ... it might go down but it worth a shot to buy it between 0.5 and 0.8 because we can come back to 8 or 10 but the downside is limited as if we close below 0.5 you get out
Barkworth
⋅
@magnum375, Yes, I agree with that. Buy between 0.5 and 0.8, then hold you breath for a bounce. But the company's financials are not good at all. Less than one year cash runway, last quarter lost a lot of market share to peers. We have to be very careful with this asset.
Thanks! And have a great weekend :-)
magnum375
⋅
@Barkworth, well we will see , thanks for your interesting thought
have a great weekend
No man, I never bought them. When they announced that reverse split and new shelf prospectus, I figured to just stay sidelined. How about you?
magnum375
⋅
@Barkworth, I still have a little amount invested I will keep it if we still above 7 but if we close below I m out
Barkworth
⋅
@magnum375, I think this is the dip to buy. Sell off after the 12-1 split. Earnings is scary, I think their valuation is pretty good right now, though that doesn't mean there isn't downside, but the one thing that worries me, is the 2.4B goodwill for Medreleaf they have on that balance sheet. We could see a 1B write off there. Though in terms of assets, etc. they are pretty good value right now. We'll have to see them meet the revenue targets though, and improved EBITDA. Earnings on May 14th. I am on the fence. I may play. They could surprise. Though most peers missed.
Barkworth
⋅
Choices, choices... It is a trade though, not a hold. Not yet.